TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T00696 XX ID T00696 XX DT 15.10.1992 (created); ewi. DT 30.01.2015 (updated); sup. CO Copyright (C), QIAGEN. XX FA PR B XX SY NR3C3; NR3C3b; PR; PR B; progesterone receptor; progesterone receptor form B; progesterone receptor isoform B. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G003936 PGR; HGNC: PGR. XX CL C0002; CC (rec); 2.1.1.1.3.2. XX SZ 933 AA; 99.0 kDa (cDNA) (calc.), 114-120 kDa (SDS) XX SQ MTELKAKGPRAPHVAGGPPSPEVGSPLLCRPAAGPFPGSQTSDTLPEVSAIPISLDGLLF SQ PRPCQGQDPSDEKTQDQQSLSDVEGAYSRAEATRGAGGSSSSPPEKDSGLLDSVLDTLLA SQ PSGPGQSQPSPPACEVTSSWCLFGPELPEDPPAAPATQRVLSPLMSRSGCKVGDSSGTAA SQ AHKVLPRGLSPARQLLLPASESPHWSGAPVKPSPQAAAVEVEEEDSSESEESAGPLLKGK SQ PRALGGAAAGGGAAACPPGAAAGGVALVPKEDSRFSAPRVALVEQDAPMAPGRSPLATTV SQ MDFIHVPILPLNHALLAARTRQLLEDESYDGGAGAASAFAPPRTSPCASSTPVAVGDFPD SQ CAYPPDAEPKDDAYPLYSDFQPPALKIKEEEEGAEASARSPRSYLVAGANPAAFPDFPLG SQ PPPPLPPRATPSRPGEAAVTAAPASASVSSASSSGSTLECILYKAEGAPPQQGPFAPPPC SQ KAPGASGCLLPRDGLPSTSASAAAAGAAPALYPALGLNGLPQLGYQAAVLKEGLPQVYPP SQ YLNYLRPDSEASQSPQYSFESLPQKICLICGDEASGCHYGVLTCGSCKVFFKRAMEGQHN SQ YLCAGRNDCIVDKIRRKNCPACRLRKCCQAGMVLGGRKFKKFNKVRVVRALDAVALPQPL SQ GVPNESQALSQRFTFSPGQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQ SQ LGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAP SQ DLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQ SQ FEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRA SQ LSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK XX SC translated from EMBL:M15716 XX FT 1 564 PF02161; Progesterone receptor. FT 264 745 PF00478; IMP dehydrogenase / GMP reductase domai. FT 564 635 SM00399; c4gold. FT 564 639 PS51030; NUCLEAR_REC_DBD_2. FT 565 640 PF00105; Zinc finger, C4 type (two domains). FT 720 884 SM00430; holi. FT 723 908 PF00104; Ligand-binding domain of nuclear hormon. FT 904 918 AF-2 domain (transactivation activity) [12]. XX SF alternative promoter usage and, concomitantly, alternative translation initiation gives rise to isoform A T01661 [2]; SF dimerization and nuclear translocation is inhibited by hsp90 [4]; XX FF activator or repressor in response to progesterone; FF both PR isoforms exhibit different promoter specificity [2]; XX IN T08740 batf3; rat, Rattus norvegicus. IN T18805 batf3; human, Homo sapiens. IN T04074 brca1; human, Homo sapiens. IN T06595 C/EBPbeta-FL; human, Homo sapiens. IN T06596 C/EBPbeta-LIP; human, Homo sapiens. IN T01487 cyclinA; human, Homo sapiens. IN T02776 DAX1; human, Homo sapiens. IN T09944 DAX1; human, Homo sapiens. IN T00992 Hsp90; human, Homo sapiens. IN T08741 jdp2; rat, Rattus norvegicus. IN T19032 jdp2; human, Homo sapiens. IN T01661 PR A; human, Homo sapiens. IN T00696 PR B; human, Homo sapiens. IN T08891 PSF-isoform1; human, Homo sapiens. IN T08171 PSF; human, Homo sapiens. IN T21552 SRC-1; Mammalia. IN T02121 TAFII110; fruit fly, Drosophila melanogaster. XX MX M00960 V$PR_Q2. MX M03799 V$PR_Q6. XX BS R00973. BS R00974. BS R00975. BS R00976. BS R00978. BS R40171. BS R40172. BS R40173. BS R66028. BS R71596. BS R71599. BS R14315. BS R14316. BS R12328. BS R12329. BS R39279. BS R34883. BS R23811. BS R71581. BS R71583. BS R57486. BS R57499. BS R57502. BS R57508. BS R02234. BS R29385. BS R57260. BS R34881. XX DR TRANSPATH: MO000019617. DR TRANSCOMPEL: C00603. DR PATHODB: MT010691. DR EMBL: M15716; HSPGRR. DR EMBL: X51730; HSPREC. DR UniProtKB: P06401-1; XX RN [1]; RE0000379. RX PUBMED: 3416833. RA Hecht A., Berkenstam A., Stroemstedt P.-E., Gustafsson J.-A., Sippel A. E. RT A progesterone responsive element maps to the far upstream steroid DNase hypersensitive site of chicken lysozyme chromatin RL EMBO J. 7:2063-2073 (1988). RN [2]; RE0000463. RX PUBMED: 2328727. RA Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H., Chambon P. RT Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B RL EMBO J. 9:1603-1614 (1990). RN [3]; RE0001752. RX PUBMED: 2172797. RA Forman B. M., Samuels H. H. RT Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model RL Mol. Endocrinol. 4:1293-1301 (1990). RN [4]; RE0002418. RX PUBMED: 1986383. RA DeMarzo A. M., Beck C. A., Onate S. A., Edwards D. P. RT Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein RL Proc. Natl. Acad. Sci. USA 88:72-76 (1991). RN [5]; RE0003737. RX PUBMED: 3283939. RA Evans R. M. RT The steroid and thyroid hormone receptor superfamily RL Science 240:889-895 (1988). RN [6]; RE0003738. RX PUBMED: 1587864. RA Meyer M.-E., Quirin-Stricker C., Lerouge T., Bocqel M.-T., Gronemeyer H. RT A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms RL J. Biol. Chem. 267:10882-10887 (1992). RN [7]; RE0003739. RX PUBMED: 1518826. RA Rehberger P., Rexin M., Gehring U. RT Heterotetrameric structure of the human progesterone receptor RL Proc. Natl. Acad. Sci. USA 89:8001-8005 (1992). RN [8]; RE0003740. RX PUBMED: 1312348. RA Edwards D. P., Estes P. A., Fadok V. A., Bona B. J., Onate S., Nordeen S. K., Welch W. J. RT Heat shock alters the composition of the heteromeric steroid receptor complexes and enhances receptor activity in vivo RL Biochemistry 31:2482-2491 (1992). RN [9]; RE0003745. RX PUBMED: 3551956. RA Misrahi M., Atger M., D'Auriol L., Loosfelt H., Meriel C., Fridlansky F., Guichon-Mantel A., Galibert F., Milgrom E. RT Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem RL Biochem. Biophys. Res. Commun. 143:740-748 (1987). RN [10]; RE0003750. RX PUBMED: 1730721. RA Shemshedini L., Ji J., Brou C., Chambon P., Gronemeyer H. RT In vivo acticity of the transcription activation functions of the progesterone receptor RL J. Biol. Chem. 267:1834-1839 (1992). RN [11]; RE0013625. RX PUBMED: 10219237. RA Nuclear Receptors Nomenclature Committee. RT A unified nomenclature system for the nuclear receptor superfamily RL Cell 97:161-163 (1999). RN [12]; RE0016449. RX PUBMED: 10428842. RA Hong H., Yang L., Stallcup M. R. RT Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3 RL J. Biol. Chem. 274:22618-22626 (1999). RN [13]; RE0030408. RX PUBMED: 12771131. RA Agoulnik I. U., Krause W. C., Bingman W. E. 3rd, Rahman H. T., Amrikachi M., Ayala G. E., Weigel N. L. RT Repressors of androgen and progesterone receptor action. RL J. Biol. Chem. 278:31136-48 (2003). RN [14]; RE0044354. RX PUBMED: 11773445. RA Christian M., Pohnke Y., Kempf R., Gellersen B., Brosens J. J. RT Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells RL Mol. Endocrinol. 16:141-54 (2002). RN [15]; RE0047476. RX PUBMED: 12101239. RA Wardell S. E., Boonyaratanakornkit V., Adelman J. S., Aronheim A., Edwards D. P. RT Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator. RL Mol. Cell. Biol. 22:5451-5466 (2002). RN [16]; RE0047660. RX PUBMED: 12727880. RA Wiper-Bergeron N., Wu D., Pope L., Schild-Poulter C., Hache R. J. RT Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. RL EMBO J. 22:2135-2145 (2003). RN [17]; RE0047842. RX PUBMED: 15668243. RA Dong X., Shylnova O., Challis J. R., Lye S. J. RT Identification and characterization of the protein-associated splicing factor as a negative co-regulator of the progesterone receptor. RL J. Biol. Chem. 280:13329-13340 (2005). RN [18]; RE0051005. RX PUBMED: 16109739. RA Ma Y., Katiyar P., Jones L. P., Fan S., Zhang Y., Furth P. A., Rosen E. M. RT The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells. RL Mol. Endocrinol. 20:14-34 (2006). RN [19]; RE0054750. RX PUBMED: 15486045. RA Skildum A., Faivre E., Lange C. A. RT Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. RL Mol. Endocrinol. 19:327-339 (2005). XX //